An Unusual Case of Multifocal Central Serous Chorioretinopathy with Low Serum Cortisol Managed Using Eplerenone

Overview

Journal Indian J Ophthalmol

Specialty Ophthalmology

Date 2018 Dec 22

PMID 30574936

Citations 3

Authors

Kanika Aggarwal

Aniruddha Agarwal

Vishali Gupta

Affiliations

Soon will be listed here.

Abstract

In this report, we describe a rare case of a 44-year-old Asian male with acute central serous chorioretinopathy (CSC) with bullous exudative retinal detachment. Endocrinology evaluation revealed hypothalamic-pituitary-adrenal axis suppression with low serum cortisol. Furthermore, neuroimaging revealed the presence of a pituitary microadenoma. He was treated with systemic eplerenone and hydrocortisone. After 12 weeks, bullous detachment completely resolved. Our case is a unique description of acute CSC with underlying low serum cortisol levels that responded to treatment with mineralocorticoid antagonist. This case highlights the various endocrine abnormalities other than the raised serum cortisol that can occur in patients with CSC.

Citing Articles

Bilateral multifocal and recurrent chorioretinopathy - case report.

Cristea A, Stan C Rom J Ophthalmol. 2023; 66(4):373-381.

PMID: 36589323 PMC: 9773119. DOI: 10.22336/rjo.2022.67.

Bilateral bullous central serous chorioretinopathy treated with PDT and eplerenone.

Anderson W, Smith B Am J Ophthalmol Case Rep. 2022; 28:101739.

PMID: 36393907 PMC: 9640324. DOI: 10.1016/j.ajoc.2022.101739.

Bullous Central Serous Chorioretinopathy: A Rare and Atypical Form of Central Serous Chorioretinopathy. A Systematic Review.

Sartini F, Menchini M, Posarelli C, Casini G, Figus M Pharmaceuticals (Basel). 2020; 13(9).

PMID: 32872388 PMC: 7559580. DOI: 10.3390/ph13090221.

References

Hussain D, GASS J . Idiopathic central serous chorioretinopathy. Indian J Ophthalmol. 1999; 46(3):131-7. View

Thoelen A, Bernasconi P, Schmid C, Messmer E . Central serous chorioretinopathy associated with a carcinoma of the adrenal cortex. Retina. 2000; 20(1):98-9. DOI: 10.1097/00006982-200001000-00020. View

Arndt C, Sari A, Ferre M, Parrat E, Courtas D, De Seze J . Electrophysiological effects of corticosteroids on the retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2001; 42(2):472-5. View

Haimovici R, Rumelt S, Melby J . Endocrine abnormalities in patients with central serous chorioretinopathy. Ophthalmology. 2003; 110(4):698-703. DOI: 10.1016/S0161-6420(02)01975-9. View

Rezai K, Eliott D . Optical coherence tomographic findings in pregnancy-associated central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2004; 242(12):1014-6. DOI: 10.1007/s00417-003-0850-2. View

Rajput R, Dhingra A, Kumar K, Sen J . Infiltrative ophthalmopathy and primary hypothyroidism: a rare clinical manifestation of a common disease. Postgrad Med J. 2009; 85(999):40-2. DOI: 10.1136/pgmj.2008.071704. View

Kashkouli M, Pakdel F, Kiavash V, Heidari I, Heirati A, Jam S . Hyperthyroid vs hypothyroid eye disease: the same severity and activity. Eye (Lond). 2011; 25(11):1442-6. PMC: 3213650. DOI: 10.1038/eye.2011.186. View

Zhao M, Celerier I, Bousquet E, Jeanny J, Jonet L, Savoldelli M . Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. J Clin Invest. 2012; 122(7):2672-9. PMC: 3386817. DOI: 10.1172/JCI61427. View

Parchand S, Gupta V, Gupta A, Dogra M, Singh R, Sharma A . Dark spot in fibrinous central serous chorioretinopathy masquerading choroiditis. Ocul Immunol Inflamm. 2013; 21(3):201-6. DOI: 10.3109/09273948.2013.765015. View

10.

Bousquet E, Beydoun T, Zhao M, Hassan L, Offret O, Behar-Cohen F . Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study. Retina. 2013; 33(10):2096-102. DOI: 10.1097/IAE.0b013e318297a07a. View

11.

Farzan K, Rezaei L, Ghanbari H, Dehghani A . Central serous chorioretinopathy following kidney transplantation. Saudi J Kidney Dis Transpl. 2014; 25(3):615-20. DOI: 10.4103/1319-2442.132208. View

12.

Salz D, Pitcher 3rd J, Hsu J, Regillo C, Fineman M, Elliott K . Oral eplerenone for treatment of chronic central serous chorioretinopathy: a case series. Ophthalmic Surg Lasers Imaging Retina. 2015; 46(4):439-44. DOI: 10.3928/23258160-20150422-06. View

13.

Ghadiali Q, Jung J, Yu S, Patel S, Yannuzzi L . CENTRAL SEROUS CHORIORETINOPATHY TREATED WITH MINERALOCORTICOID ANTAGONISTS: A ONE-YEAR PILOT STUDY. Retina. 2015; 36(3):611-8. DOI: 10.1097/IAE.0000000000000748. View

14.

Gergely R, Kovacs I, Schneider M, Resch M, Papp A, Recsan Z . MINERALOCORTICOID RECEPTOR ANTAGONIST TREATMENT IN BILATERAL CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: A COMPARATIVE STUDY OF EXUDATIVE AND NONEXUDATIVE FELLOW EYES. Retina. 2016; 37(6):1084-1091. DOI: 10.1097/IAE.0000000000001303. View

15.

Yang D, Eliott D . Systemic Mineralocorticoid Antagonists in the Treatment of Central Serous Chorioretinopathy. Semin Ophthalmol. 2016; 32(1):36-42. DOI: 10.1080/08820538.2016.1228418. View

16.

Rahimy E, Pitcher 3rd J, Hsu J, Adam M, Shahlaee A, Samara W . A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROL PILOT STUDY OF EPLERENONE FOR THE TREATMENT OF CENTRAL SEROUS CHORIORETINOPATHY (ECSELSIOR). Retina. 2017; 38(5):962-969. DOI: 10.1097/IAE.0000000000001649. View

17.

Schwartz R, Habot-Wilner Z, Martinez M, Nutman A, Goldenberg D, Cohen S . Eplerenone for chronic central serous chorioretinopathy-a randomized controlled prospective study. Acta Ophthalmol. 2017; 95(7):e610-e618. DOI: 10.1111/aos.13491. View

18.

Nicholson B, Atchison E, Idris A, Bakri S . Central serous chorioretinopathy and glucocorticoids: an update on evidence for association. Surv Ophthalmol. 2017; 63(1):1-8. DOI: 10.1016/j.survophthal.2017.06.008. View

19.

YARD A, Kadowitz P . Studies on the mechanism of hydrocortisone potentiation of vasoconstrictor responses to epinephrine in the anesthetized animal. Eur J Pharmacol. 1972; 20(1):1-9. DOI: 10.1016/0014-2999(72)90209-9. View

20.

Chumbley L, Frank R . Central serous retinopathy and pregnancy. Am J Ophthalmol. 1974; 77(2):158-60. DOI: 10.1016/0002-9394(74)90667-9. View